Christopher Young, DPM
Foot Surgery · Wilmington, NCNPI 1639161946
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (46.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Southtech Orthopedics at 46.4% of the total. Reporting peaked in 2022 at $1,388 and has fallen 87.2% since, to $177 in 2025.
Across 26 payments — averaging $99.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Southtech Orthopedics$1K
- Smith+Nephew$620
- Organogenesis Inc.$252
- Treace Medical Concepts, Inc.$237
- Amgen$116
- Tricoast Surgical Solutions LLC$47
- plus $111 from 4 others
What the payments were for
- Speaking & faculty fees$1235%
- Travel & lodging$1526%
- Food & beverage$1,11043%
- Education$1,20046%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Southtech Orthopedics | 1 | $1,200 |
| Smith+Nephew | 8 | $620 |
| Organogenesis Inc. | 7 | $252 |
| Treace Medical Concepts, Inc. | 2 | $237 |
| Amgen | 1 | $116 |
| Tricoast Surgical Solutions LLC | 1 | $47 |
| Convatec Inc. | 2 | $36 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| Polynovo North America LLC | 1 | $25 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GRAFIX PL$388
- STRAVIX PL$257
- Lapiplasty System$152
- Oasis$135
- Apligraf$123
- Dermagraft$123
- Puraply/Affinity/NuTech$123
- Grafix XC$122
- Stravix$122
- KRYSTEXXA$116
How this compares
Too few foot surgery providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 48 | $787 |
| Gentamicin Sulfate | 15 | $530 |
| Doxycycline Hyclate | 46 | $353 |
| Ketoconazole | 19 | $330 |
| Lidocaine | 11 | $308 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 39 | $277 |
| Cephalexin | 28 | $195 |
| Ciprofloxacin Hcl | 16 | $114 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $103 |
| Mupirocin | 18 | $100 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Wilmington
- Kerry SmithWilmington$102
- Thomas ArneWinston Salem$20K
- Robert KleinEden$5K
- Bryan SatterwhiteShallotte$4K
- Scott BasingerCharlotte$2K
- Bennett EvansFayetteville$1K
- Reagan ParrishMorehead City$733
- Devin RicksFayetteville$472
- Tori Simmons LewisCharlotte$370
- Rosemary MichelFayetteville$163
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.